Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
- PMID: 16806952
- DOI: 10.1016/j.nbd.2006.04.007
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Abstract
Parkinson's disease (PD) is characterized by the formation of intracytoplasmic inclusions, which contain alpha-synuclein (alpha-syn) protein. While most profound neurodegeneration is seen in the dopamine (DA) synthesizing neurons located in the ventral midbrain, it is unclear why some DA cell groups are more susceptible than others. In the midbrain, the degeneration of the substantia nigra (SN) DA neurons is severe, whereas the involvement of the ventral tegmental area (VTA) neurons is relatively spared. In the present study, we overexpressed human A53T alpha-syn in the VTA neurons and found that A53T toxicity did not affect their survival. There was, however, a mild functional impairment seen as altered open field locomotor activity. Overexpression of A53T in the SN, on the other hand, led to profound cell loss. These results suggest that the selective susceptibility of nigral DA neurons is at least in part associated with factor(s) involved in handling of alpha-syn that is not shared by the VTA neurons. Secondly, these results highlight the fact that impaired but surviving neurons can have a substantial impact on DA-dependent behavior and should therefore be considered as a critical part of animal models where novel therapeutic interventions are tested.
Similar articles
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.Nat Neurosci. 2005 Dec;8(12):1742-51. doi: 10.1038/nn1570. Epub 2005 Nov 20. Nat Neurosci. 2005. PMID: 16299504
-
Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.Neurobiol Dis. 2009 Sep;35(3):385-98. doi: 10.1016/j.nbd.2009.05.023. Epub 2009 Jun 6. Neurobiol Dis. 2009. PMID: 19505575
-
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.Acta Neuropathol. 2006 Aug;112(2):115-26. doi: 10.1007/s00401-006-0096-2. Epub 2006 Jun 22. Acta Neuropathol. 2006. PMID: 16791599 Review.
-
The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.Ann N Y Acad Sci. 2004 Dec;1035:231-49. doi: 10.1196/annals.1332.015. Ann N Y Acad Sci. 2004. PMID: 15681811 Review.
Cited by
-
Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion.Behav Brain Res. 2013 Jan 15;237:157-63. doi: 10.1016/j.bbr.2012.09.031. Epub 2012 Sep 24. Behav Brain Res. 2013. PMID: 23018122 Free PMC article.
-
Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory.J Neurosci. 2008 Jul 30;28(31):7797-807. doi: 10.1523/JNEUROSCI.1885-08.2008. J Neurosci. 2008. PMID: 18667612 Free PMC article.
-
Molecular Determinants of A9 Dopaminergic Neurons.Neuromolecular Med. 2025 May 21;27(1):43. doi: 10.1007/s12017-025-08861-1. Neuromolecular Med. 2025. PMID: 40397062 Review.
-
Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.J Neural Transm (Vienna). 2011 Mar;118(3):361-9. doi: 10.1007/s00702-010-0434-3. Epub 2010 Jun 17. J Neural Transm (Vienna). 2011. PMID: 20556443
-
Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease.Mol Neurodegener. 2010 Oct 28;5:43. doi: 10.1186/1750-1326-5-43. Mol Neurodegener. 2010. PMID: 21029459 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous